Study guide
3.2 Informed Consent, Refusal of Treatment & Advance Directives
Certified Professional in Health Care Risk Management CPHRM
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Patient Safety Culture & Event Analysis
1.1 Patient Safety Culture & Just Culture Frameworks 1.2 Incident Reporting, Near-Miss Analysis & Sentinel Events 1.3 Root Cause Analysis (RCA) & Failure Mode Effects Analysis (FMEA) 1.4 Assessing Safety Culture and Staff Awareness 1.5 Corrective Action Plans and Improvement Follow-Up
2 Chapter 2: Safety Education, Engagement & Staff Support
2.1 Designing Risk Management and Patient Safety Education Programs 2.2 Engaging Patients and Families in Reducing Risk 2.3 Tracking National and Local Patient Safety Initiatives 2.4 Critical Incident Debriefing and Second Victim Support
3 Chapter 3: Clinical Risk Consultation & Patient Rights
3.1 Disclosure of Adverse Events & Apology Laws 3.2 Informed Consent, Refusal of Treatment & Advance Directives 3.3 Surrogate Decision Makers and Consent for Minors 3.4 Managing Disruptive Patients, Families, and Visitors 3.5 Release of Information: Subpoenas, Law Enforcement, and Warrants 3.6 Abuse Allegations and Mandatory Reporting Obligations 3.7 Medical Record Documentation Review and Risk Mitigation 3.8 Safe Medication Practices, Infection Control & Diagnostic Safety
4 Chapter 4: Risk Financing & Insurance Principles
4.1 Fundamentals of Healthcare Risk Financing & Exposure Identification 4.2 Commercial Insurance Structures & Coverage Types (Occurrence vs. Claims-Made) 4.3 Alternative Risk Financing: Captives, Risk Retention Groups & Self-Insurance 4.4 Specialty Coverage Lines: D&O, Cyber, Workers' Compensation, and Property 4.5 Program Layering: Retentions, Excess, Umbrella, and Reinsurance
5 Chapter 5: Risk Financing Operations & Contracts
5.1 Actuarial Concepts, Loss Reserving & Retained Risk Calculations 5.2 Contractual Risk Transfer, Indemnification & Hold Harmless Clauses 5.3 Loss Run Analysis and Historical Loss Trending 5.4 Policy Notice Provisions and Timely Reporting Obligations 5.5 Investigating Non-Clinical Accidents and Liability Exposures
6 Chapter 6: Legal Framework & Liability
6.1 Federal Healthcare Statutes: HIPAA/HITECH, EMTALA & PSQIA 6.2 Fraud and Abuse Laws: Stark Law, Anti-Kickback Statute & False Claims Act 6.3 Medical Malpractice Tort Law & Legal Duties of Care 6.4 Involuntary Detention, Psychiatric Holds, and Restraint Law
7 Chapter 7: Regulatory Compliance & Accreditation
7.1 Accreditation Standards: The Joint Commission, CMS & State Licensing 7.2 CMS Conditions of Participation and Deemed Status 7.3 Regulatory Reporting Obligations & Government Investigations 7.4 National Practitioner Data Bank Reporting and Querying 7.5 Safe Medical Device Act, Device Reporting, and Tracking Logs 7.6 Patient Complaints and Grievance Resolution 7.7 The Organizational Compliance Plan and Workforce Compliance 7.8 Bioethics, End-of-Life Care & Ethics Committee Consultation
8 Chapter 8: Risk Management Program Operations
8.1 Enterprise Risk Management (ERM) Frameworks in Healthcare 8.2 Risk Management Program Structure, Governance & Board Reporting 8.3 Policy Development, Clinical Credentialing & Staff Oversight 8.4 Risk Assessments for New and Existing Services 8.5 Supervising and Developing Risk Management Staff 8.6 Annual Risk Program Goals and Measuring Effectiveness
9 Chapter 9: Operational Risk Coordination
9.1 Managing the Disruptive Practitioner and Behavioral Programs 9.2 Committee Support and Enterprise Event Report Management 9.3 Service of Process and Accepting Legal Documents 9.4 Policies for High-Risk Clinical and Operational Domains
10 Chapter 10: Emergency Management, Technology & Environmental Risk
10.1 Healthcare Emergency Preparedness & Business Continuity Planning 10.2 Health IT, Cybersecurity, Telehealth & EHR Risk Management 10.3 Environmental Safety, Medical Equipment & Workplace Violence Prevention
11 Chapter 11: Claims Management
11.1 Potentially Compensable Events (PCEs) & Early Investigation 11.2 Carrier, Broker, and TPA Notification Workflows 11.3 Claims Reserve Establishment & Loss Valuation 11.4 Claim Evaluation, Exposure Analysis, and Resolution Strategy 11.5 Reporting High-Exposure Cases and Aggregate Claims Experience
12 Chapter 12: Litigation Oversight
12.1 Medical Malpractice Litigation Management & Discovery 12.2 Attorney-Client Privilege, Work Product, and Discoverability 12.3 Evidence Preservation, Legal Holds, and Spoliation 12.4 Alternative Dispute Resolution (ADR), Mediation & Settlement Strategy 12.5 Supporting Insured Defendants Through the Litigation Process
3.2 Informed Consent, Refusal of Treatment & Advance Directives
Key Takeaways Explain This Topic AI
Informed consent is an ongoing educational dialogue, not merely a signed form; the obtaining clinician (physician or advanced practice provider) bears the non-delegable legal duty to discuss risks, benefits, alternatives, and expected outcomes.
Legal standards for adequacy of disclosure differ by jurisdiction: the 'reasonable physician standard' evaluates practice customary to peers, while the 'reasonable patient standard' evaluates what a prudent patient would consider material to their decision.
Decision-making capacity is a clinical evaluation of a patient's ability to understand, appreciate, reason, and communicate a choice regarding a specific medical decision at a given time, distinct from legal competency determined by a court.
Under the Patient Self-Determination Act (PSDA) of 1990, healthcare institutions receiving Medicare/Medicaid funding must inquire about advance directives, document their existence in the medical record, and provide written policy information without conditioning care on their execution.
POLST/MOLST forms translate patient advance directives into actionable, standardized medical orders that are legally binding across the entire continuum of care, including pre-hospital Emergency Medical Services (EMS).
Last updated: July 2026
2.2 Informed Consent, Refusal of Treatment & Advance Directives
Exam Focus: Clinical risk managers must navigate the complex legal and ethical landscape of patient autonomy. CPHRM candidates must understand informed consent legal standards, capacity assessment vs. legal competency, refusal of treatment protocols, Against Medical Advice (AMA) documentation, advance directive enforcement, and the operational mandates of the Patient Self-Determination Act (PSDA).
Legal Foundations of Informed Consent
Informed consent is a legal doctrine rooted in the ethical principle of patient autonomy and the common law right to self-determination. Legally, performing a medical procedure without valid consent constitutes civil battery (unpermitted touching) or medical negligence (failure to meet the standard of disclosure).
Informed consent is not a static paper form; it is an interactive educational dialogue between a credentialed licensed independent practitioner (LIP)—such as a physician, surgeon, or advanced practice provider—and the patient. Nurses and risk managers may witness the signature on a consent document, but the legal duty to inform cannot be delegated to non-prescribing staff.
Legal Standards of Disclosure
Jurisdictions apply one of two primary legal standards to evaluate whether a clinician provided adequate disclosure prior to obtaining consent:
Legal Disclosure Standard Basis of Standard Key Question Evaluated by Court Landmark Legal Precedent
Reasonable Physician Standard (Professional Standard) What a reasonably prudent physician in the same or similar community would disclose under similar circumstances. "Did the clinician disclose information customary among professional peers?" Traditional common law rule; expert medical testimony required.
Reasonable Patient Standard (Materiality Standard) What a reasonably prudent patient in the patient's position would consider material to making an informed decision. "Would a reasonable person deem this specific risk material to deciding whether to undergo treatment?" Canterbury v. Spence (D.C. Cir. 1972); focused on patient comprehension.
Essential Elements of Valid Informed Consent
For informed consent to be legally valid, four fundamental elements must be established:
Decision-Making Capacity: The patient possesses the cognitive capability to understand relevant information, appreciate consequences, reason through options, and express a choice.
Adequate Disclosure: The clinician explains the nature and purpose of the proposed intervention, material risks (including risk of death or serious disability), anticipated benefits, reasonable alternatives (including no treatment), and expected outcomes.
Comprehension: Information is delivered in plain language tailored to the patient's literacy level, primary language (utilizing medical interpreters when necessary), and cognitive state.
Voluntariness: The patient exercises free choice without coercion, duress, or undue influence from healthcare providers or family members.
Statutory & Common Law Exceptions to Consent
Informed consent is legally excused under three narrow circumstances:
Emergency Privilege: Immediate treatment is necessary to prevent death or serious irreversible harm, the patient is incapacitated, and no surrogate or prior expressed refusal is available.
Therapeutic Privilege: A rare, narrowly construed doctrine where full disclosure would pose a severe, immediate threat of psychological harm to the patient (requires extensive clinical documentation and risk manager review).
Patient Waiver: The patient explicitly declines to receive detailed risk disclosures and delegates decision-making to a designated surrogate or trusted clinician.
Refusal of Treatment & Against Medical Advice (AMA)
Competent adult patients retain the absolute right to refuse any medical treatment, diagnostic procedure, or life-sustaining intervention, even when refusal will inevitably lead to disability or death.
Decision-Making Capacity vs. Legal Competency
Risk managers must maintain a clear distinction between clinical capacity and legal competency:
- CLINICAL CAPACITY LEGAL COMPETENCY
- Evaluated by licensed clinicians Adjudicated exclusively by a probate/civil court
- Decision-specific and time-specific Global, formal legal status declaration
- Fluctuates based on medical condition Requires appointment of legal guardian
- Assessed at bedside without court order Governed by state probate laws
- Risk Mitigation for Against Medical Advice (AMA) Discharges
When a patient with decision-making capacity insists on leaving a healthcare facility or refusing recommended therapy against clinical advice, risk managers must ensure comprehensive Informed Refusal documentation to defend against future abandonment or failure-to-warn claims.
Key elements of robust AMA management:
Conduct and document a formal assessment of decision-making capacity.
Explain the specific, serious medical risks of leaving, including organ damage, permanent disability, or death.
Offer alternative treatments, modified outpatient care plans, and necessary discharge medications/prescriptions.
Explicitly inform the patient that they are welcome to return to the facility at any time for care.
Obtain the patient's signature on an AMA form; if the patient refuses to sign, document the refusal with a witness signature.
Advance Directives & Patient Self-Determination Act (PSDA)
The Patient Self-Determination Act (PSDA) of 1990 mandates that healthcare organizations receiving Medicare or Medicaid funds must:
Provide written information to adult patients regarding their rights under state law to make medical decisions and execute advance directives.
Document in the patient's medical record whether an advance directive has been executed.
Maintain written policies and procedures regarding advance directives and educate staff and the community.
Ensure non-discrimination in care delivery based on whether a patient has executed an advance directive.
Primary Types of Advance Directives
Advance Directive Instrument Legal Scope & Function Clinical Execution Trigger
Living Will Written directive specifying desired or withheld medical treatments (e.g., mechanical ventilation, artificial nutrition/hydration). Triggers only when patient is diagnosed with a terminal condition or persistent vegetative state.
Durable Power of Attorney for Healthcare (DPOA-HC) Legal document designating a surrogate decision-maker (healthcare proxy/agent) to make decisions when patient lacks capacity. Triggers whenever the patient loses decision-making capacity for any healthcare choice.
POLST / MOLST (Physician/Medical Orders for Life-Sustaining Treatment) Translation of patient preferences into actionable, binding medical orders signed by a licensed clinician. Actionable immediately across all settings, including pre-hospital Emergency Medical Services (EMS).
Resolving Surrogate & Family Conflicts
When family members dispute a patient's advance directives or surrogate designations, risk managers must prioritize the patient's documented prior wishes. If surrogate decision-makers act contrary to expressed patient intent or best interests, the risk manager should convene an urgent Clinical Ethics Committee consultation or seek emergency judicial appointment of a temporary guardian.